Brief: Palisade Bio Reports Third Quarter 2022 Financial Results, Provides Business Update
Nov 14 (Reuters) - Palisade Bio Inc PALI.O :
* PALISADE BIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
AND
PROVIDES BUSINESS UPDATE
* QTRLY LOSS PER SHARE $0.08
Source text for Eikon: ID:nGNX8PhLC2
Further company coverage: PALI.O
Recent news on Palisade Bio
See all newsPalisade Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Palisade Bio Q2 net loss widens on higher R&D costs
Brief: Palisade Bio Q2 EPS USD -0.05
Palisade Bio Inc expected to post a loss of 5 cents a share - Earnings Preview
Brief: Palisade Bio Inc - May Offer And Sell Up To $300 Million Of Securities - SEC Filing